Co-evolution of tumor cells and their microenvironment

Trends in Genetics

Volumn 25, Issue 1, 2009, Pages 30-38

  Polyak, Kornelia ^a,b   Haviv, Izhak ^c,d   Campbell, Ian G ^d,e  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

^e PETER MACCALLUM CANCER CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER PREVENTION; CANCER THERAPY; CARCINOGENESIS; CELL COMPARTMENTALIZATION; EPIGENETICS; GENE EXPRESSION; GENOTYPE; MOLECULAR EVOLUTION; PRIORITY JOURNAL; REVIEW; STROMA CELL;

ANIMALS; CELL COMMUNICATION; EPIGENESIS, GENETIC; EVOLUTION; FEMALE; GENES, TUMOR SUPPRESSOR; HUMANS; LOSS OF HETEROZYGOSITY; MALE; MODELS, GENETIC; MUTATION; NEOPLASMS; STROMAL CELLS;

EID: 58149345546     PISSN: 01689525     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tig.2008.10.012     Document Type: Review

References (75)

1. Merlo L.M., et al. Cancer as an evolutionary and ecological process. Nat. Rev. Cancer 6 (2006) 924-935
2. Anderson A.R., et al. Tumor morphology and phenotypic evolution driven by selective pressure from the microenvironment. Cell 127 (2006) 905-915
3. Bhowmick N.A., et al. Stromal fibroblasts in cancer initiation and progression. Nature 432 (2004) 332-337
4. Hu M., and Polyak K. Microenvironmental regulation of cancer development. Curr. Opin. Genet. Dev. 18 (2008) 27-34
5. Nelson C.M., and Bissell M.J. Of extracellular matrix, scaffolds, and signaling: tissue architecture regulates development, homeostasis, and cancer. Annu. Rev. Cell Dev. Biol. 22 (2006) 287-309
6. Orimo A., and Weinberg R.A. Stromal fibroblasts in cancer: a novel tumor-promoting cell type. Cell Cycle 5 (2006) 1597-1601
7. Tlsty T.D., and Coussens L.M. Tumor stroma and regulation of cancer development. Annu. Rev. Pathol. 1 (2006) 119-150
8. Allinen M., et al. Molecular characterization of the tumor microenvironment in breast cancer. Cancer Cell 6 (2004) 17-32
9. Cunha G.R., et al. Role of stroma in carcinogenesis of the prostate. Differentiation 70 (2002) 473-485
10. Yauch R.L., et al. A paracrine requirement for hedgehog signalling in cancer. Nature 455 (2008) 406-410
11. Hu M., et al. Regulation of in situ to invasive breast carcinoma transition. Cancer Cell 13 (2008) 394-406
12. Barcellos-Hoff M.H. The potential influence of radiation-induced microenvironments in neoplastic progression. J. Mammary Gland Biol. Neoplasia 3 (1998) 165-175
13. Ohuchida K., et al. Radiation to stromal fibroblasts increases invasiveness of pancreatic cancer cells through tumor-stromal interactions. Cancer Res. 64 (2004) 3215-3222
14. Krtolica A., and Campisi J. Cancer and aging: a model for the cancer promoting effects of the aging stroma. Int. J. Biochem. Cell Biol. 34 (2002) 1401-1414
15. Parrinello S., et al. Stromal-epithelial interactions in aging and cancer: senescent fibroblasts alter epithelial cell differentiation. J. Cell Sci. 118 (2005) 485-496
16. Maffini M.V., et al. The stroma as a crucial target in rat mammary gland carcinogenesis. J. Cell Sci. 117 (2004) 1495-1502
17. Medina D., and Kittrell F. Stroma is not a major target in DMBA-mediated tumorigenesis of mouse mammary preneoplasia. J. Cell Sci. 118 (2005) 123-127
18. Bhowmick N.A., et al. TGF-β signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia. Science 303 (2004) 848-851
19. Kuperwasser C., et al. Reconstruction of functionally normal and malignant human breast tissues in mice. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 4966-4971
20. Radisky D.C., et al. Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability. Nature 436 (2005) 123-127
21. Hill R., et al. Selective evolution of stromal mesenchyme with p53 loss in response to epithelial tumorigenesis. Cell 123 (2005) 1001-1011
22. Chari N.S., and McDonnell T.J. The sonic hedgehog signaling network in development and neoplasia. Adv. Anat. Pathol. 14 (2007) 344-352
23. Dvorak H.F. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N. Engl. J. Med. 315 (1986) 1650-1659
24. Schafer M., and Werner S. Cancer as an overhealing wound: an old hypothesis revisited. Nat. Rev. Mol. Cell Biol. 9 (2008) 628-638
25. Moran E.M. Epidemiological and clinical aspects of nonsteroidal anti-inflammatory drugs and cancer risks. J. Environ. Pathol. Toxicol. Oncol. 21 (2002) 193-201
26. Blagosklonny M.V. Oncogenic resistance to growth-limiting conditions. Nat. Rev. Cancer 2 (2002) 221-225
27. Marusyk A., and DeGregori J. Declining cellular fitness with age promotes cancer initiation by selecting for adaptive oncogenic mutations. Biochim. Biophys. Acta 1785 (2008) 1-11
28. Hussain S.P., et al. Nitric oxide is a key component in inflammation-accelerated tumorigenesis. Cancer Res. 68 (2008) 7130-7136
29. Bluff J.E., et al. Tissue factor, angiogenesis and tumour progression. Breast Cancer Res. 10 (2008) 204
30. Kaplan R.N., et al. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 438 (2005) 820-827
31. Kerbel R.S., et al. Endothelial progenitor cells are cellular hubs essential for neoangiogenesis of certain aggressive adenocarcinomas and metastatic transition but not adenomas. Proc. Natl. Acad. Sci. U. S. A. 105 (2008) E54
32. Shaked Y., et al. Rapid chemotherapy-induced acute endothelial progenitor cell mobilization: implications for antiangiogenic drugs as chemosensitizing agents. Cancer Cell 14 (2008) 263-273
33. Orimo A., et al. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 121 (2005) 335-348
34. Karnoub A.E., et al. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 449 (2007) 557-563
35. McAllister S.S., et al. Systemic endocrine instigation of indolent tumor growth requires osteopontin. Cell 133 (2008) 994-1005
36. Vogelstein B., and Kinzler K.W. Cancer genes and the pathways they control. Nat. Med. 10 (2004) 789-799
37. Bartek J., et al. Patterns of expression of the p53 tumour suppressor in human breast tissues and tumours in situ and in vitro. Int. J. Cancer 46 (1990) 839-844
38. Califano J., et al. Genetic progression and clonal relationship of recurrent premalignant head and neck lesions. Clin. Cancer Res. 6 (2000) 347-352
39. Liu S., et al. BRCA1 regulates human mammary stem/progenitor cell fate. Proc. Natl. Acad. Sci. U. S. A. 105 (2008) 1680-1685
40. Moinfar F., et al. Concurrent and independent genetic alterations in the stromal and epithelial cells of mammary carcinoma: implications for tumorigenesis. Cancer Res. 60 (2000) 2562-2566
41. Kurose K., et al. Frequent somatic mutations in PTEN and TP53 are mutually exclusive in the stroma of breast carcinomas. Nat. Genet. 32 (2002) 355-357
42. Weber F., et al. Variability in organ-specific EGFR mutational spectra in tumour epithelium and stroma may be the biological basis for differential responses to tyrosine kinase inhibitors. Br. J. Cancer 92 (2005) 1922-1926
43. Weber F., et al. Total-genome analysis of BRCA1/2-related invasive carcinomas of the breast identifies tumor stroma as potential landscaper for neoplastic initiation. Am. J. Hum. Genet. 78 (2006) 961-972
44. Patocs A., et al. Breast-cancer stromal cells with TP53 mutations and nodal metastases. N. Engl. J. Med. 357 (2007) 2543-2551
45. Qiu W., et al. No evidence of clonal somatic genetic alterations in cancer-associated fibroblasts from human breast and ovarian carcinomas. Nat. Genet. 40 (2008) 650-655
46. Walter K., et al. Pancreatic cancer associated fibroblasts display normal allelotypes. Cancer Biol. Ther. 7 (2008) 882-888
47. Winter J.M., et al. Multiple-criterion evaluation of reported mutations: a proposed scoring system for the intragenic somatic mutation literature. Cancer Biol. Ther. 5 (2006) 360-370
48. Shipitsin M., et al. Molecular definition of breast tumor heterogeneity. Cancer Cell 11 (2007) 259-273
49. Kern S.E. Progressive genetic abnormalities in human cancer. In: Mendelsohn J., et al. (Eds). Molecular Basis of Cancer (2001), W.B. Saunders Co. 41-69
50. Muller A., et al. Involvement of chemokine receptors in breast cancer metastasis. Nature 410 (2001) 50-56
51. Hu M., et al. Distinct epigenetic changes in the stromal cells of breast cancers. Nat. Genet. 37 (2005) 899-905
52. Fiegl H., et al. Breast cancer DNA methylation profiles in cancer cells and tumor stroma: association with HER-2/neu status in primary breast cancer. Cancer Res. 66 (2006) 29-33
53. Hanson J.A., et al. Gene promoter methylation in prostate tumor-associated stromal cells. J. Natl. Cancer Inst. 98 (2006) 255-261
54. Jiang L., et al. Global hypomethylation of genomic DNA in cancer-associated myofibroblasts. Cancer Res. 68 (2008) 9900-9908
55. Dudley A.C., et al. Calcification of multipotent prostate tumor endothelium. Cancer Cell 14 (2008) 201-211
56. Watanabe N., et al. Gene expression profile analysis of rheumatoid synovial fibroblast cultures revealing the overexpression of genes responsible for tumor-like growth of rheumatoid synovium. Biochem. Biophys. Res. Commun. 294 (2002) 1121-1129
57. Weaver V.M., et al. β4 integrin-dependent formation of polarized three-dimensional architecture confers resistance to apoptosis in normal and malignant mammary epithelium. Cancer Cell 2 (2002) 205-216
58. Krause S., et al. A novel 3D in vitro culture model to study stromal-epithelial interactions in the mammary gland. Tissue Eng. Part C Methods 14 (2008) 261-271
59. Ellis L.M., and Hicklin D.J. VEGF-targeted therapy: mechanisms of anti-tumour activity. Nat. Rev. Cancer 8 (2008) 579-591
60. Kurose K., et al. Genetic model of multi-step breast carcinogenesis involving the epithelium and stroma: clues to tumour-microenvironment interactions. Hum. Mol. Genet. 10 (2001) 1907-1913
61. Wernert N., et al. Presence of genetic alterations in microdissected stroma of human colon and breast cancers. Anticancer Res. 21 (2001) 2259-2264
62. Wernert N., et al. Presence of genetic alterations in microdissected stroma of human colon and breast cancers. J. Mol. Med. 78 (2000) B30
63. Paterson R.F., et al. Molecular genetic alterations in the laser-capture-microdissected stroma adjacent to bladder carcinoma. Cancer 98 (2003) 1830-1836
64. Tuhkanen H., et al. Genetic alterations in the peritumoral stromal cells of malignant and borderline epithelial ovarian tumors as indicated by allelic imbalance on chromosome 3p. Int. J. Cancer 109 (2004) 247-252
65. Pelham R.J., et al. Identification of alterations in DNA copy number in host stromal cells during tumor progression. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 19848-19853
66. Moinfar F., et al. Macro-environment of breast carcinoma: frequent genetic alterations in the normal appearing skins of patients with breast cancer. Mod. Pathol. 21 (2008) 639-646
67. Burt E.C., et al. Genomic alterations associated with loss of heterozygosity for TP53 in Li-Fraumeni syndrome fibroblasts. Br. J. Cancer 83 (2000) 467-472
68. Campbell I.G., et al. Breast-cancer stromal cells with TP53 mutations. N. Engl. J. Med. 358 (2008) 1634-1635
69. Adany R., et al. Altered expression of chondroitin sulfate proteoglycan in the stroma of human colon carcinoma. Hypomethylation of PG-40 gene correlates with increased PG-40 content and mRNA levels. J. Biol. Chem. 265 (1990) 11389-11396
70. Adany R., and Iozzo R.V. Hypomethylation of the dEcoRIn proteoglycan gene in human colon cancer. Biochem. J. 276 (1991) 301-306
71. Wood M., et al. X-linked dominant growth suppression of transplanted tumors in C57BL/6J-scid mice. Cancer Res. 65 (2005) 5690-5695
72. Hunter K.W. Host genetics and tumour metastasis. Br. J. Cancer 90 (2004) 752-755
73. Carey L.A., et al. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA 295 (2006) 2492-2502
74. Woodford-Richens K., et al. Allelic loss at SMAD4 in polyps from juvenile polyposis patients and use of fluorescence in situ hybridization to demonstrate clonal origin of the epithelium. Cancer Res. 60 (2000) 2477-2482
75. Kim B.G., et al. Smad4 signalling in T cells is required for suppression of gastrointestinal cancer. Nature 441 (2006) 1015-1019